The performance of BD FACSPresto™ for CD4 T-cell count, CD4% and hemoglobin concentration test in Ethiopia

被引:6
|
作者
Gebremicael, Gebremedhin [1 ]
Belay, Yohanes [1 ]
Girma, Fitsum [1 ]
Abreha, Yemane [1 ]
Gebreegziabxier, Atsbeha [1 ]
Tesfaye, Simret [1 ]
Messele, Zelalem [2 ]
Assefa, Yibeltal [1 ]
Bellete, Bahrie [2 ]
Kassa, Desta [1 ]
Vojnov, Lara [3 ]
机构
[1] Ethiopian Publ Hlth Inst, HIV & TB Dis Res Directorate, Addis Ababa, Ethiopia
[2] Clinton Hlth Access Initiat Inc, Addis Ababa, Ethiopia
[3] Clinton Hlth Access Initiat, Boston, MA USA
来源
PLOS ONE | 2017年 / 12卷 / 04期
关键词
LYMPHOCYTES;
D O I
10.1371/journal.pone.0176323
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction In Ethiopia, CD4+ T-cell counting is still required for all patients at baseline before antiretroviral therapy (ART) and to determine eligibility and follow-up of opportunistic infection prophylaxis. However, access to CD4+ T-cell count in rural health facilities remains a major challenge in Ethiopia like other resource-limited settings. Methodology Both capillary and venous blood was drawn from each of 325 study participant recruited in Addis Ababa and surroundings. The CD4+ T-cell count, CD4%, and hemoglobin (Hgb) were tested at one of the four study health facilities using capillary blood and BD FACSPresto (TM) device. These tests were also done at the national HIV reference laboratory, using venous blood with BD FACSCalibur (TM), Sysmex XT-1800i (TM), and BD FACSPresto (TM). Results BD FACSPresto (TM) had an absolute mean bias of -13.3 cells/mu l (-2.99%) and 28.3 cells/mu l (6.4%) using venous and capillary blood, respectively, compared with BD FACSCalibur (TM). The absolute CD4 assay on the BD FACSPresto (TM) had a regression coefficient (R-2) of 0.87 and 0.92 using capillary blood and venous blood samples, respectively, compared with BD FACSCalibur (TM). The percentage similarity of the BD FACSPresto (TM) using capillary and venous blood was 105.2% and 99.3%, respectively. The sensitivity of the FACSPresto (TM) using threshold of 500 cells/mu l for ART eligibility using capillary and venous blood was 87.9 and 94.3%, while the specificity was 91.4 and 83.8%, respectively. Furthermore, the BD FACSPresto (TM) had an absolute mean bias of -0.2 dl/mu l (0.0%) (95% LOA: -1.7, 1.3) and -0.59 dl/mu l (0.1%) (95% LOA: -1.49, 0.31) for Hgb using capillary and venous blood compared with the Sysmex XT-1800i (TM), respectively. Conclusion Our results showed acceptable agreement between the BD FACSPresto (TM) and BD FACS-Calibur (TM) for CD4+ T-cell counting and CD4%; and between the BD FACSPresto (TM) and Sysmex XT-1800i (TM) for measuring Hgb concentration.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Mechanobiology of Extravasating CD4(+) T-Cell Cytoskeleton
    Zhovmer, Alexander S.
    Dimitriadis, Emilios K.
    Ma, Xuefei
    Provenzano, Paolo P.
    Tabdanov, Erdem D.
    BIOPHYSICAL JOURNAL, 2020, 118 (03) : 281A - 281A
  • [32] An in vitro diagnostic (IVD) assay for CD4 T-cell counting on the guava CD4(DX) system
    Tyagarajan, Kamala
    Ashton, Faith
    Lam, Lee
    Nahas, Carlos
    O'Gorman, Nicholas J.
    Liu, Eileen
    Kaluoch, Okumu
    Schmitz, John L.
    Spira, Thomas J.
    O'Gorman, Maurice
    Sheppard, Haynes W.
    Mergia, Alemayehu
    Fishwild, Dianne
    O'Connell, Bernadette
    Harvey, Jeff
    Rackham, Don
    Baumgartner, Tina
    Lefebvre, Ray
    Thomae, Mya
    Bishop, David
    Ferrick, David
    Buchner, Leonard
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2007, 72B (06) : 491 - 491
  • [33] CD4 T cell cooperation is required for the in vivo activation of CD4 T cells
    Peters, Nathan C.
    Kroeger, David R.
    Mickelwright, Steven
    Bretscher, Peter A.
    INTERNATIONAL IMMUNOLOGY, 2009, 21 (11) : 1213 - 1224
  • [34] CD4 count and CD4% in African HIV-infected people
    Anglaret, X
    Sylla-Koko, F
    Diagbouga, S
    Combe, P
    Van de Perre, P
    Dabis, F
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1998, 27 (05) : 928 - 929
  • [35] REGULATION OF T-CELL FUNCTIONS BY THE CD4 MOLECULE - ANALYSIS OF A CD4- LEUKEMIC T-CELL MUTANT BEFORE AND AFTER STABLE EXPRESSION OF CD4 CDNA
    LEDERMAN, S
    YELLIN, MJ
    DEMARTINO, JA
    DAUGHERTY, BL
    FOELDVARI, I
    CLEARY, AM
    MARK, GE
    CHESS, L
    FASEB JOURNAL, 1991, 5 (05): : A995 - A995
  • [36] CD4 lymphocyte count: TRAx CD4 test kit versus conventional flow cytometry.
    Saah, AJ
    Spruill, C
    Hoover, DR
    Prevots, R
    Taylor, E
    Margolick, JB
    Vlahov, D
    CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) : 137 - 137
  • [37] External Quality Assessment on CD4+ T-Cell Count Using in-House Proficiency Testing Panels for CD4 Count Laboratories in Addis Ababa, Ethiopia
    Yibalih, Natnael Kidanu
    Wolday, Dawit
    Kinde, Samuel
    Weldearegay, Gebru Mulugeta
    ETHIOPIAN JOURNAL OF HEALTH SCIENCES, 2019, 29 (03) : 309 - 320
  • [38] Ligation of CD4 concomitant to activation induces primary CD4(+) T-cell adhesion and pseudopodia formation in vitro
    Palomo, LF
    DecoteRicardo, D
    Pirmez, C
    Vieira, RM
    DosReis, GA
    CELLULAR IMMUNOLOGY, 1996, 172 (01) : 43 - 51
  • [39] Task-shifting of CD4 T cell count monitoring by the touchscreen-based Muse™ Auto CD4/CD4% single-platform system for CD4 T cell numeration: Implication for decentralization in resource-constrained settings
    Kouabosso, Andre
    Mossoro-Kpinde, Christian Diamant
    Bouassa, Ralph-Sydney Mboumba
    Longo, Jean De Dieu
    Simaleko, Marcel Mbeko
    Gresenguet, Gerard
    Belec, Laurent
    JOURNAL OF IMMUNOLOGICAL METHODS, 2018, 455 : 95 - 98
  • [40] Performance of the BD-FACS Presto for CD4 count and hemoglobin measurement in a district hospital and rural laboratory in Ghana
    Moran, Zelda
    Sacks, Jilian A.
    Frimpong, Francis Kwabena
    Frimpong, Atta Boahen
    Ben Amor, Yanis
    PLOS ONE, 2019, 14 (02):